trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Coronavirus antibodies confer immunity against reinfection

the verdict
OVERSTATED
true in a weaker form than the claim states
Recorded sources
6 sources for · 3 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that coronavirus antibodies confer immunity against reinfection?

Partly. While coronavirus antibodies and neutralizing titers contribute significantly to immune defense and reduce the severity of subsequent exposures, they do not provide absolute sterilizing immunity, as evidenced by documented reinfections and waning neutralization against emerging variants.

Verdict: OVERSTATED · 6 sources for, 3 against · Last checked

The analysis

The retrieved literature shows a nuanced picture: while numerous studies (e.g., [0], [2], [3], [4], [9], [10]) confirm that coronavirus antibodies and neutralizing titers play a central role in humoral defense and correlate with protection against reinfection, other studies and clinical observations ([1], [5], [7]) demonstrate that sterilizing immunity is incomplete and breakthrough reinfections frequently occur due to waning responses or viral evolution. Therefore, the claim is contested rather than unconditionally supported.

what the evidence does support

Coronavirus antibodies contribute significantly to immune defense and reduce the risk of reinfection, though they do not provide absolute immunity.

Evidence for · 6
Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection
2021
Long-term studies show that RBD-specific memory B cells and neutralizing antibodies are maintained or increase up to 6 months post-infection.
Get citation
Abayasingam, A., Balachandran, H., Agapiou, D., Hammoud, M., Rodrigo, C., Keoshkerian, E., Li, H., Brasher, N. A., Christ, D., Rouet, R., Burnet, D., Grubor-Bauk, B., Rawlinson, W., Turville, S., Aggarwal, A., Stella, A., Fichter, C., Brilot, F., Mina, M. M., Post, J., Hudson, B., Gilroy, N., Dwyer, D., Sasson, S., Tea, F., Pilli, D., Kelleher, A., Tedla, N., Lloyd, A., Martinello, M., & Bull, R. (2021). Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection. doi.org. https://doi.org/10.1016/j.xcrm.2021.100228

Evidence against · 3
Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamster
2021
Animal models demonstrate that primary SARS-CoV-2 infection is insufficient to elicit complete sterilizing immunity, leaving subjects susceptible to reinfection.
Get citation
Brustolin, M., Rodón, J., Concepción, M. L. R. d. l., Ávila-Nieto, C., Cantero, G., Pérez, M., Te, N., Noguera-Julián, M., Guallar, V., Valencia, A., Roca, N., Izquierdo-Useros, N., Blanco, J., Clotet, B., Bensaid, A., Carrillo, J., Vergara-Alert, J., & Segalés, J. (2021). Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamster. doi.org. https://doi.org/10.1080/22221751.2021.1913974

See more details
More for · 5
Protective roles and protective mechanisms of neutralizing antibodies against SARS-CoV-2 infection and their potential clinical implications
2023
Neutralizing antibodies play a central prophylactic role by blocking viral entry and conferring humoral defense against SARS-CoV-2.
Get citation
Abebe, E. C. & Dejenie, T. A. (2023). Protective roles and protective mechanisms of neutralizing antibodies against SARS-CoV-2 infection and their potential clinical implications. doi.org. https://doi.org/10.3389/fimmu.2023.1055457

Immunologic memory to SARS-CoV-2 in convalescent COVID-19 patients at 1 year postinfection
2021
Robust humoral and cellular responses, including sustained neutralizing antibody levels, persist in convalescent patients at 1 year post-infection.
Get citation
Hou, H., Zhang, Y., Tang, G., Luo, Y., Liu, W., Cheng, C., Jiang, Y., Xiong, Z., Wu, S., Sun, Z., Xu, S., Fan, X., & Wang, F. (2021). Immunologic memory to SARS-CoV-2 in convalescent COVID-19 patients at 1 year postinfection. doi.org. https://doi.org/10.1016/j.jaci.2021.09.008

Rapid quantitative screening assay for SARS-CoV-2 neutralizing antibodies using HiBiT-tagged virus-like particles
2020
Assays confirm that functional neutralizing antibodies correlate with protective immunity against coronavirus reinfection.
Get citation
Miyakawa, K., Jeremiah, S. S., Ohtake, N., Matsunaga, S., Yamaoka, Y., Nishi, M., Morita, T., Saji, R., Nishii, M., Kimura, H., Hasegawa, H., Takeuchi, I., & Ryo, A. (2020). Rapid quantitative screening assay for SARS-CoV-2 neutralizing antibodies using HiBiT-tagged virus-like particles. doi.org. https://doi.org/10.1093/jmcb/mjaa047

Reinfection-Driven Accumulation of SARS-CoV-2 Antibodies: A 36-Month Longitudinal Study in Austrian Blood Donors.
2026
Longitudinal data demonstrate that sustained antibody activity and repeated antigenic exposure contribute to robust rebuilding humoral immunity.
Get citation
O, K., AD, H., W, L., L, W., N, B., C, G., C, J., V, N., H, N., N, H., T, O., E, R., & S, L. (2026). Reinfection-Driven Accumulation of SARS-CoV-2 Antibodies: A 36-Month Longitudinal Study in Austrian Blood Donors.. doi.org. https://doi.org/10.3390/diagnostics16020195

Immune responses associated with protection from SARS-CoV-2 infection.
2026
Multivariate analyses confirm that neutralizing antibodies remain significantly associated with protection from subsequent infection.
Get citation
A, R., WS, L., KJ, S., J, A., MC, T., AW, C., D, C., HX, T., AK, W., JA, J., DS, K., MP, D., & SJ, K. (2026). Immune responses associated with protection from SARS-CoV-2 infection.. doi.org. https://doi.org/10.1016/j.vaccine.2026.128579

More against · 2
How Protective are Antibodies to SARS-CoV-2, the Main Weapon of the B-Cell Response?
2022
Reviews indicate that antibodies alone confer only partial protection against infection or reinfection, emphasizing the need for robust cellular immunity.
Get citation
Pons, S., Uhel, F., Frapy, E., Sereme, Y., Zafrani, L., Aschard, H., & Skurnik, D. (2022). How Protective are Antibodies to SARS-CoV-2, the Main Weapon of the B-Cell Response?. doi.org. https://doi.org/10.1007/s12015-022-10477-y

A case with SARS-CoV-2 reinfection from India
2021
Clinical reports of reinfection in patients with detectable IgG but lacking neutralizing antibodies suggest that prior infection does not always prevent reinfection.
Get citation
Munivenkatappa, A., Sahay, R., Deshpande, G., Patil, D., Shete, A., Sapkal, G., Kumar, R., Narayana, M., Yadav, P., & Shettar, V. (2021). A case with SARS-CoV-2 reinfection from India. doi.org. https://doi.org/10.1016/j.ijmmb.2021.09.010

Related receipts

What does the evidence say?

The retrieved literature shows a nuanced picture: while numerous studies (e.g., [0], [2], [3], [4], [9], [10]) confirm that coronavirus antibodies and neutralizing titers play a central role in humoral defense and correlate with protection against reinfection, other studies and clinical observations ([1], [5], [7]) demonstrate that sterilizing immunity is incomplete and breakthrough reinfections frequently occur due to waning responses or viral evolution. Therefore, the claim is contested rather than unconditionally supported.

What would change this verdict?

Coronavirus antibodies contribute significantly to immune defense and reduce the risk of reinfection, though they do not provide absolute immunity.

Receipt History
first checked04 Aug 2026
judged → OVERSTATED · 004 Aug 2026
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work